3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Gastrointestinal
1
Conditions
Head and Neck Neoplasms
1
Interventions
Cisplatin
28
toripalimab
14
Radiotherapy
12
Gemcitabine
12
Capecitabine
11
Radiotherapy, Intensity-Modulated
10
pembrolizumab
9
Surgical Procedures, Operative
9
Docetaxel
9
tislelizumab
8
Carboplatin
7
Drug Therapy
6
Blood Specimen Collection
6
anlotinib
5
Taxes
5
Paclitaxel
5
Nivolumab
5
Fluorouracil
5
Cetuximab
5
130-nm albumin-bound paclitaxel
5
Thyroxine
4
Magnetic Resonance Spectroscopy
4
Cyclophosphamide
4
trametinib
3
sintilimab
3
camrelizumab
3
Radiation
3
Observation
3
Injections
3
Immune Checkpoint Inhibitors
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Electric Stimulation
×
Head & Neck
×
Clear all
NCT07074392
2025-08-19
SpARES
McMaster University
Phase NA
Not yet recruiting
38 enrolled